Back
The Descartes Systems Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
36
DSGX
The Descartes Systems Group
Last Price:
$99.01
Seasonality Move:
3.45%
Buy
78
KYMR
Kymera Therapeutics
Last Price:
$46.44
Seasonality Move:
30.84%
Sell
36
The Descartes Systems Group (DSGX)
is a Sell
Is The Descartes Systems Group a Buy, Sell or Hold?
-
The current The Descartes Systems Group [DSGX] share price is $98.97. The Score for DSGX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
DSGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $46.44. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DSGX Stock Price Chart
What is The Descartes Systems Group's stock price today?
-
The The Descartes Systems Group share price today is $98.97The current trend is moderately bearish and DSGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.44The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
DSGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.29 | Sell |
Relative Strength Index (14 RSI): | 35.16 | Sell |
Chaikin Money Flow: | 218259 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.32 - 115.66) | Sell |
Bollinger Bands (100): | (100.54 - 114.88) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.29 | Buy |
Relative Strength Index (14 RSI): | 70.12 | Buy |
Chaikin Money Flow: | -104674 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.09 - 46.91) | Buy |
Bollinger Bands (100): | (27.32 - 40.74) | Buy |
DSGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.34 | Sell |
20-day SMA: | 107.36 | Sell |
50-day SMA: | 106.65 | Sell |
200-day SMA: | 108.43 | Sell |
8-day EMA: | 100.47 | Sell |
20-day EMA: | 104.26 | Sell |
50-day EMA: | 97.63 | Buy |
200-day EMA: | 49.48 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.25 | Sell |
20-day SMA: | 40.55 | Buy |
50-day SMA: | 33.93 | Buy |
200-day SMA: | 39.63 | Buy |
8-day EMA: | 46.17 | Buy |
20-day EMA: | 42.19 | Buy |
50-day EMA: | 37.15 | Buy |
200-day EMA: | 36.82 | Buy |
The Descartes Systems Group Earnings Growth & DSGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $0.23 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
The Descartes Systems Group Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |